Allegra-d Allergy And Congestion Tablet, Film Coated, Extended Release
Product Images NDC 41167-4320

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Allegra-d Allergy And Congestion (NDC 41167-4320). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chattem, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panelndc 41167-4320-7non-drowsyallegra-d®allergy & Congestionfexofenadine HCl 180 mg/antihistaminepseudoephedrine HCl 240 mg/nasal Decongestantextended Release Tablets15 Tablets (Allegra D Allergy And Congestion 24 Hr 01)

Principal Display Panelndc 41167-4320-7non-drowsyallegra-d®allergy & Congestionfexofenadine HCl 180 mg/antihistaminepseudoephedrine HCl 240 mg/nasal Decongestantextended Release Tablets15 Tablets (Allegra D Allergy And Congestion 24 Hr 01)
This is a medicine for allergy and congestion relief. It contains fexofenadine HCI 180 mg which is an antihistamine and pseudoephedrine HCI 240 mg which is a nasal decongestant in extended-release tablets format. It can provide relief for both indoor and outdoor allergies. However, some of the text is not readable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.